Viridian Therapeutics, Inc.\DE (VRDN) Net income 2016–2025
Viridian Therapeutics, Inc.\DE (VRDN) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$342.6MFY2025 · since FY2016: -$17.3M → -$342.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$342.6M | -26.9% |
| FY2024 | -$269.9M | -13.5% |
| FY2023 | -$237.7M | -83.0% |
| FY2022 | -$129.9M | -63.6% |
| FY2021 | -$79.4M | +28.3% |
| FY2020 | -$110.7M | -164.4% |
| FY2019 | -$41.9M | -28.0% |
| FY2018 | -$32.7M | -23.4% |
| FY2017 | -$26.5M | -53.5% |
| FY2016 | -$17.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice